These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30747082)

  • 1. Two Novel Tri-Aryl Derivatives Attenuate the Invasion-Promoting Effects of Stromal Mesenchymal Stem Cells on Breast Cancer.
    Moradi K; Barneh F; Irian S; Amini M; Moradpoor R; Amanzadeh A; Choopani S; Rahimi H; Ghodselahi T; Boujar MM; Salimi M
    Anticancer Agents Med Chem; 2019; 19(8):1002-1011. PubMed ID: 30747082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
    Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
    Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
    Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Epithelial-mesenchymal Transition in Response to Treatment with Metformin and Y27632 in Breast Cancer Cell Lines.
    Leonel C; Ferreira LC; Borin TF; Moschetta MG; Freitas GS; Haddad MR; de Camargos Pinto Robles JA; Aparecida Pires de Campos Zuccari D
    Anticancer Agents Med Chem; 2017; 17(8):1113-1125. PubMed ID: 28042775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
    Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
    Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
    BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.
    Han D; Wu G; Chang C; Zhu F; Xiao Y; Li Q; Zhang T; Zhang L
    Oncotarget; 2015 Dec; 6(38):40907-19. PubMed ID: 26517513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.
    Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q
    Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells.
    Lin S; Lyu X; Yu J; Sun L; Du D; Lai Y; Li H; Wang Y; Zhang L; Yin H; Yuan S
    Phytomedicine; 2016 Sep; 23(10):1053-63. PubMed ID: 27444351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hard antler extract inhibits invasion and epithelial-mesenchymal transition of triple-negative and Her-2
    Xu G; Zhao H; Xu J; Zhang Y; Qi X; Shi A
    J Ethnopharmacol; 2021 Apr; 269():113705. PubMed ID: 33346025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-cadherin mediates the migration of bone marrow-derived mesenchymal stem cells toward breast tumor cells.
    Choi S; Yu J; Kim W; Park KS
    Theranostics; 2021; 11(14):6786-6799. PubMed ID: 34093853
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).
    Martin FT; Dwyer RM; Kelly J; Khan S; Murphy JM; Curran C; Miller N; Hennessy E; Dockery P; Barry FP; O'Brien T; Kerin MJ
    Breast Cancer Res Treat; 2010 Nov; 124(2):317-26. PubMed ID: 20087650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moscatilin Reverses EMT Progression and its Resulting Enhanced Invasion and Migration by Affecting the TGF-β Signaling Pathway in Bladder Cancer.
    Li Z; Yang J; Chen L; Chen P; Liu C; Long X; Chen B; Long J
    Anticancer Agents Med Chem; 2024; 24(14):1074-1084. PubMed ID: 38808719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin Treatment Combined with TGF-β Silencing Inhibits Epithelial- Mesenchymal Transition in CF41 Canine Mammary Cancer Cell Line.
    Custódio PR; Colombo J; Ventura FV; Castro TB; Zuccari DAPC
    Anticancer Agents Med Chem; 2020; 20(8):989-997. PubMed ID: 32264814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-
    Sun X; Chang X; Wang Y; Xu B; Cao X
    Biomed Res Int; 2019; 2019():9241769. PubMed ID: 31341911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
    Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
    Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
    Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
    Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.